Our aim is to study the effects of varying the two acyl moieties in synthesized N 4 ,N 9 -diacyl spermines on siRNA formulations and their delivery efficiency in cell lines. Six novel asymmetrical lipopolyamines: [N 4 -cholesteryloxy-3-carbonyl-N 9 -oleoyl-, N 4 -decanoyl-N 9 -oleoyl-, N 4 -decanoyl-N 9 -stearoyl-, N 4 -lithocholoyl-N 9 -oleoyl-, N 4 -myristoleoyl-N 9 -myristoyl-, and N 4 oleoyl-N 9 -stearoyl]-1,12-diamino-4,9-diazadodecane were assessed for their abilities to bind to siRNA, studied using a RiboGreen intercalation assay, and to form nanoparticles. Their siRNA delivery efficiencies were quantified in FEK4 primary skin cells and in an immortalized cancer cell line (HtTA) using a fluorescein-tagged siRNA, and compared with formulations of N 4 ,N 9 dioleoyl-1,12-diamino-4,9-diazadodecane and of a leading transfecting agent, TransIT-TKO.
INTRODUCTION
Small (or short) interfering RNA (siRNA) delivery is a branch of polynucleic acid delivery that has many potential clinical applications and progress is being made towards RNA interference (RNAi) realising its potential and becoming an efficient medicine for the treatment of a wide range of diseases. 1, 2 Following the discovery of gene silencing in petunia flowers 3, 4 and then in animal cells, 5, 6 siRNA is making significant progress in clinical trials, however, key obstacles still remain to be overcome. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] siRNA is a 21-24 double stranded nucleic acid with a relatively large molecular weight (~13 kDa) and ~40 negative charges (from the 21 bp phosphates). These physicochemical properties ensure siRNA molecules have poor intracellular uptake and so the major challenge lies in the ability to deliver siRNA efficiently to its site of action, the cytoplasm. Due to the efficiency of RNase, siRNA undergoes fast enzymatic degradation in serum. 21 A wide variety of cationic lipids (lipoplexes) [21] [22] [23] [24] [25] [26] and cationic polymers (polyplexes) 27, 28 are being investigated as non-viral carriers for siRNA. They are more efficient than administering naked siRNA, but the in vitro/in vivo correlation of cationic lipid formulations is not good due to the various biological barriers and the interaction with serum components. 25 Formulation and stability studies of siRNA are therefore important, but few structure-activity relationship (SAR) studies have been reported. Such SAR studies are urgently required for non-viral vectors in siRNA delivery as there is no immediate correlation between the efficiency of a vector used for pDNA and for siRNA delivery. 1, 18 We are studying how novel lipopolyamines interact with a fluorescein-tagged siRNA in order to produce nanometre-sized particles suitable for transfecting cells with high efficiency and low toxicity. Our non-viral gene therapy (NVGT) delivery system focus is on the design of simple, practical formulations using lipopolyamines composed of two long-carbon chains or one chain and a steroid covalently bound to a polyamine e.g. the tetra-amine spermine (1,12-diamino-4,9 diazadodecane), a natural RNA binding agent. [29] [30] [31] The essential requirements for polynucleotide delivery are set out in detail in some of our recent research papers [32] [33] [34] [35] [36] Briefly these are: lipoplex mediated transport of siRNA through the cell membrane and thereby delivery to the cytosol.
Overcoming the various lipid bilayer barriers requires the lipopolyamine to mask the polyanionic character of the siRNA as a nanoparticle (lipoplex) by electrostatic charge neutralisation, an important first step in NVGT. As the site of action of siRNA is in the cytosol, there is no requirement to enter the nucleus (as for pDNA), but the siRNA lipoplex must efficiently afford protection from the high enzyme activity of RNase which otherwise results in fast hydrolysis with no chance of a therapeutic endpoint. The rationale for this series of novel asymmetrical cationic lipids is also set out in the previous and following papers. 33, 36 We have chosen naturally occurring lipids and covalently bound them in different pairs to the naturally occurring polyamine spermine.
Then, without any pre-preparation of liposomes, we titrate a fluorescein-tagged siRNA against the cationic lipids in order to investigate if they are suitable for efficient, non-toxic delivery to target primary (hard-to-transfect) cells, by forming nanoparticles which will efficiently enter cells in NVGT. Such bio-nanoparticle lipoplex formulations leading to gene knock-down might be efficient in transfection, particularly if they work in the presence of serum nucleases (e.g. RNase) and if they show high cell viability. Such low toxicity might be especially predicted where the (asymmetrical) lipids of the formulation accurately mimic the constituents of human lipid bilayers. Herein we report our investigation on the formulation of siRNA with variation in the two lipid moieties regiospecifically covalently bound to the secondary amines of spermine.
We make sequential changes to chain length from C10 (decanoyl) to C18 (oleoyl), and we incorporate two steroid moieties, cholesteryl from essentially planar AB-cholesterol 37, 38 and lithocholoyl 39, 40 from the naturally occurring cis-AB bile acid steroid lithocholic acid. There is therefore the potential for different interactions with cellular bilayers and, subsequent to absorptive endocytosis, for fusion with and thereby weakening of the endosomal bilayer. The six new synthetic lipopolyamines spontaneously form lipoplexes with siRNA which are assessed by physico-and bio-chemical techniques: target cell transfection efficiency (in the presence of serum thereby demonstrating RNase protection) through both delivery of a fluorescein-tagged siRNA and silencing of EGFP reporter gene stably expressed in HeLa cells, using both primary and cancer cell lines, confocal microscopy, cell viability measured in a 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) cytotoxicity assay. 41, 42 We compare our results with those obtained with the non-liposomal lipopolyamine Lipogen ® (N 4 ,N 9 -dioleoyl spermine) 43, 44 and also with a leading transfecting agent, TransIT-TKO. permanganate used for the detection of polyamines, was as previously reported. 35 All the synthesized lipopolyamines were homogenous on silica gel thin-layer chromatography (TLC) (CH 2 Cl 2 -MeOH-conc. aq. NH 3 25:10:1, v/v/v) and showed satisfactory 1 H nuclear magnetic resonance (NMR) and 13 C NMR spectroscopy as previously reported 35 and low-and highresolution mass spectrometric (HRMS) Fast Atom Bombardment (FAB) data (positive ion mode, reported as m/z and within 5 ppm) using m-nitrobenzyl alcohol as the matrix. N 4 ,N 9 -Dioleoyl spermine was prepared as previously reported. 43, 44 Particle Size. The average particle size for each lipoplex formed at a highly efficient N/P charge ratio of delivery was determined using a NanoSight LM10 (NanoSight Ltd, Salisbury, UK).
MATERIALS AND METHODS

Materials
All measurements were carried out on lipoplexes prepared from siRNA (25 pmol) in HEPES buffer (0.2 mL) at pH 7.4. Results were analysed with the Nanoparticle Tracking Analysis (NTA) software.

Cell Culture. Three cell lines were used in the transfection experiments, a human primary skin fibroblast cells FEK4 45, 46 derived from a foreskin explant, a human cervix carcinoma, HeLa derivative and transformed cell line (HtTA), 47, 48 and HeLa cells stably expressing EGFP. 49, 50 The
HtTA cells being stably transfected with a tetracycline-controlled transactivator (tTA) consisting of the tet repressor fused with the activating domain of virion protein 16 of the herpes simplex virus (HSV). Cells were cultured as previously reported. 35 The For EGFP gene silencing we used HeLa cells stably expressing EGFP, trypsinized at confluency 80-90%, and seeded at a density of 65,000 cells/well in 24-well plates. Cells were incubated for 24 h at 37 °C in 5% CO 2 v/v prior to transfection. The lipoplexes were prepared by mixing the specified amounts of the transfection reagent that resulted in best siRNA delivery in OptiMEM serum-free medium (50 L), with 15 L of siRNA (1 M) in OptiMEM serum-free medium. The solutions were mixed for 2-3 s using a vortex mixer. On the day of transfection, the lipoplex solutions were added to wells containing Dulbecco's Modified Eagle's Medium (DMEM) (10% FCS) such that each well contained 15 pmol siRNA. The plates were then incubated for 48 h at 37 °C in 5% CO 2 v/v before the assay.
In Vitro Cytotoxicity (MTT) Assay. FEK4 and HtTA cells were seeded in 96-well plates at 8,000 cells/well and incubated for 24 h at 37 °C in 5% CO 2 v/v. Lipoplexes complexed with siRNA were added in the same way as in the transfection protocol. After incubation for 44 h, the media were replaced with fresh media (90 µL) and sterile filtered MTT solution (10 µL, 5 mg/mL) to reach a final concentration of 0.5 mg/mL. 43, 44 Then the plates were incubated for a further 4 h at 37 °C in an atmosphere of 5% CO 2 v/v. The percent viability was detected as previously reported. 35 Flow Cytometry (FACS). were seeded at a density of 65,000 cells/well in 24-well plates that have round-glass cover slips (12 mm in diameter) and were incubated for 24 h prior to transfection which was carried out as described above. After that 48 h incubation, the cell culture media in each well were aspirated and the cells washed with PBS (3 x 0.5 mL). The cell membrane was then stained with wheat germ agglutinin (WGA) conjugated to Alexa Fluor ® 555. The WGA-Alexa Fluor ® 555 working solution was adjusted to a concentration of 5 µg/mL in Hank's balanced salt solution without phenol red.
The cells were incubated for 10 min in the dye working solution at 37 °C, 5% CO 2 in the dark. The cells were then washed with PBS (3 x 0.5 mL) and then fixed with 4% paraformaldehyde in PBS for 20 min at 20 °C in the dark. The cover slips were then removed from each well, washed with PBS (2 x 0.5 mL), left to dry briefly in air, and then mounted on glass slides using Mowiol In nature, RNA polyanionic charges are neutralised by polyammonium ion counterions.
The high cellular concentrations of positively charged polyamines (e.g. spermine, spermidine) have higher affinity for RNA than for DNA wound around the basic proteins, histones. [29] [30] [31] The rational design and synthesis of six novel asymmetrical N 4 ,N 9 -disubstituted spermines, comprised of different aliphatic chains and steroids, are set out in the preceding paper 35 as is their ready ability to fuse with plasma membranes. They were each prepared via the key intermediate N 1 ,N 12ditrifluoroacetyl-N 4 -t-butoxycarbonyl-1,12-diamino-4,9-diazadodecane. 35 The chain lengths were varied from 10 to 18, and the level of unsaturation along the chains was also controlled in our novel siFection vectors, obtained as their free bases, four containing two different long chains: N 4decanoyl-N 9 -oleoyl-1,12-diamino-4,9-diazadodecane, N 4 -decanoyl-N 9 -stearoyl-1,12-diamino-4, 9- diazadodecane, N 4 -myristoleoyl-N 9 -myristoyl-1,12-diamino-4,9-diazadodecane, and N 4 -oleoyl-N 9stearoyl-1,12-diamino-4,9-diazadodecane, and the two steroid conjugates N 4 -cholesteryloxy-3carbonyl-N 9 -oleoyl-1,12-diamino-4,9-diazadodecane and N 4 -3α-hydroxy-5-cholan-24-carbonyl-N 9 -oleoyl-1,12-diamino-4,9-diazadodecane ( Figure 1 ). These six target N 4 ,N 9 -asymmetrical diacyl spermines were homogenous on silica gel TLC (CH 2 Cl 2 -MeOH-conc. aq. NH 3 25:10:1, v/v/v) and all showed satisfactory HRMS data (within 5 ppm). We have therefore investigated them as potential non-viral vectors in our continuing SAR studies of pDNA versus siRNA delivery in order to investigate novel lipopolyamine molecules that have different lipid moieties on N 4 ,N 9 -positions of the polyamine spermine backbone. 35 RNA Binding (RiboGreen intercalation assay). All our siRNA delivery experiments are performed in the presence of serum. From our typical delivery results with these novel lipopolyamines (Figures 4, 5, 6, and 7) we conclude that delivery increases with lipopolyamine N/P charge ratio in both cell lines. High efficiency (71-93%) of siRNA delivery was achieved on optimisation, N 4 -oleoyl-N 9 -stearoyl spermine, N 4myristoleoyl-N 9 -myristoyl spermine, and N 4 -decanoyl-N 9 -oleoyl spermine being comparable with N 4 ,N 9 -dioleoyl spermine. Therefore, whilst siRNA delivery is dose dependent, the balance of optimised delivery with toxicity (cell viability) will also have to be considered (Figure 8 ).
N4-oleoyl-N9-stearoyl spermine N4-myristoleoyl-N9-myristoyl spermine N4-decanoyl-N9-stearoyl spermine N4-decanoyl-N9-oleoyl spermine N4-cholesteryl-N9-oleoyl spermine N4-lithocholoyl-N9-oleoyl spermine
The highest efficiency of siRNA delivery into primary skin cell line FEK4 cells was found with N 4 -myristoleoyl-N 9 -myristoyl spermine (89%), N 4 -lithocholoyl-N 9 -oleoyl spermine (87%), N 4 -decanoyl-N 9 -oleoyl spermine (86%), N 4 -oleoyl-N 9 -stearoyl spermine (84%), N 4 -decanoyl-N 9stearoyl spermine (77%), and the lowest with N 4 -cholesteryloxy-3-carbonyl-N 9 -oleoyl spermine (71%). The results of siRNA delivery into cancer HtTA cells follow a similar pattern from highest efficiency with N 4 -lithocholoyl-N 9 -oleoyl spermine (93%) to lowest with N 4 -cholesteryloxy-3carbonyl-N 9 -oleoyl spermine (76%). Incorporating two asymmetrical chains or other lipid moieties, our siRNA delivery results (Figure 8 The cell viability (MTT assay) results for the siRNA lipoplexes (Figure 8 , lines) indicate that there is not a large difference in the cell viability between the commercially available TransIT-TKO, FEK4 (85%) and HtTA (75%) cells, and N 4 -myristoleoyl-N 9 -myristoyl spermine and N 4cholesteryloxy-3-carbonyl-N 9 -oleoyl spermine, next is N 4 -oleoyl-N 9 -stearoyl spermine, while N 4decanoyl-N 9 -stearoyl spermine, N 4 -decanoyl-N 9 -oleoyl spermine, and N 4 -lithocholoyl-N 9 -oleoyl spermine lipopolyamines are more toxic to both cell lines.
Lipoplex Particle Size Measurements. The particle size of the formulation is also an important factor in improving delivery. 52 Figure 2 ). Therefore, optimal siRNA delivery efficiency is not only a matter of siRNA binding and associated charge neutralisation, but also of total lipospermine content in the formulae, resulting in a net positive charge and an excess of acyl lipids.
The length and type of the aliphatic chains (the hydrophobic domain) incorporated into cationic lipids significantly affects their pDNA transfection efficiency, 17, [32] [33] [34] [35] 44 but this factor is not yet understood for siRNA delivery. This series of novel non-viral vectors is designed to mimic the composition of cell membrane phospholipid bilayers with their high percentage of asymmetrical fatty chains. We are taking advantage of having short-and long-fatty chains in the same molecule, or a saturated and an unsaturated fatty chain, or a fatty acyl chain with a steroid, mixing these different hydrophobic domains in order to facilitate inter-membrane mixing leading to endosomal escape 53 which will deliver the siRNA directly into the cytosol. Experimental evidence for this is that the di-C14 vector N 4 -myristoleoyl-N 9 -myristoyl spermine was one of the best in this series. By incorporating two different acyl moieties, and changing their length and oxidation level in a stepwise manner, we have demonstrated some structurally different examples of non-viral lipopolyamine vectors capable of siRNA lipoplex self-assembly and effecting efficient siRNA delivery. A common moiety in these effective siRNA delivery vectors is a cis-monounsaturated alkyl chain, e.g. the oleoyl group (C18), a result possibly related to the issues of hydrophobic moiety hydration or packing. [52] [53] [54] By incorporating two different lipid moieties, we have shown that all our synthesized lipopolyamines afford siRNA delivery results varying in range, and at different N/P charge ratios, and also most of the tested asymmetrical diacyl spermines are not toxic except N 4 -lithocholoyl-N 9 -oleoyl spermine and those containing saturated C10 acyl chains, e.g. N 4 -decanoyl-N 9 -stearoyl spermine. Therefore, by considering a combination of the siRNA lipoplex delivery efficiency and cell viability (Figure 8) we see that N 4 -oleoyl-N 9stearoyl spermine and N 4 -myristoleoyl-N 9 -myristoyl spermine are as effective as TransIT-TKO, typically resulting in 89% cell delivery in the presence of serum i.e. of RNase. We have shown that adding a second lipid chain is better than incorporating a steroid. luciferase gene 55 and C6 glioma cells stably expressing GFP. 56 The three lipopolyamines that showed the best balance between highly efficient fluorescein-tagged siRNA delivery and the associated cell viability (Figure 8 ) were chosen to test their abilities to knock-down EGFP reporter gene. HeLa cell transfection with siRNA, i.e. delivery and functional knock-down, using a siRNA against EFGP (siEGFP) was comparable to that achieved with TransIT-TKO (24%) as a positive control ( Figure 9 ). The EGFP expression in the transfected HeLa cells was significantly reduced Using a scrambled siRNA as a negative control (siNC, Figure 9 ), we have also demonstrated that the gene silencing achieved with all four vectors is due to sequence-specific EGFP gene knockdown and not due to other off-target or cationic lipid-related effects, e.g. cell toxicity. Using confocal laser scanning microscopy, these HeLa cells are shown to be transfected successfully with siRNA against EGFP. As the cells biosynthesize EGFP by transcription and translation, the diminution in the green fluorescence is quantifiable for post-transcriptional siRNA activity by gene silencing. siRNA lipoplexes of N 4 -myristoleoyl-N 9 -myristoyl spermine showed loss of cytosolic green fluorescence from EGFP to 34% (Figure 10, cf Figure 3 ). The cell membranes are labeled with WGA-Alexa Fluor ® 555 (shown in blue). The presence of an unsaturation center in at least one of the fatty acid chains is a common feature for effective gene knock-down with our vectors. We conclude that the delivery and knock-down results obtained with these asymmetrical lipopolyamines, values comparable to those obtained with TransIT-TKO and N 4 ,N 9 -dioleoyl spermine, can be attributed to the fusogenic ability of the unsaturated fatty acid chains (which have at least one cis-double bond) that favors (L  to H II ) phase transition, facilitating both membrane fusion and endosomal escape. 44, 49, 57 Such lipopolyamines are efficient non-viral vectors in both siRNA lipoplex delivery and gene silencing. As more and better vectors remain critical requirements for clinical siRNA delivery, 18 these SAR study results should find ready application.
